NVCR icon

NovoCure

314 hedge funds and large institutions have $5.64B invested in NovoCure in 2022 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 90 increasing their positions, 107 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

16% less repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 107

17% less capital invested

Capital invested by funds: $6.79B → $5.64B (-$1.16B)

18% less call options, than puts

Call options by funds: $69.3M | Put options by funds: $84.2M

Holders
314
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$69.3M
Puts
$84.2M
Net Calls
Net Calls Change

Top Buyers

1 +$126M
2 +$41.7M
3 +$23.7M
4
Morgan Stanley
Morgan Stanley
New York
+$20.8M
5
Jane Street
Jane Street
New York
+$17.9M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$3.67M
77
$3.39M
78
$3.36M
79
$3.31M
80
$3.09M
81
$3.04M
82
$3M
83
$2.92M
84
$2.74M
85
$2.72M
86
$2.64M
87
$2.41M
88
$2.31M
89
$2.21M
90
$2.12M
91
$2.02M
92
$1.96M
93
$1.95M
94
$1.91M
95
$1.87M
96
$1.84M
97
$1.82M
98
$1.82M
99
$1.76M
100
$1.71M